H ospital employees have the potential for exposure to a variety of hazards, from biologic hazards such as tuberculosis, hepatitis, human immunodeficiency virus, and other infections to physical hazards such as lacerations, radiation, and noise. Chemical hazards include ethylene oxide used as a sterilant; glutaraldehyde as a disinfectant; anesthetic gases for surgery; chemotherapeutic drugs in cancer treatment; film developer for x-rays: latex in the form of rubber products and gloves; and assorted paints, solvents, and other substances used for maintenance (DiBenedetto, 1995; Weaver, 1997) . In addition to these hazards, histology and pathology laboratories use formaldehyde as a preservative; xylene as a solvent; aromatic amines as dyestuff; and methacrylates for embedding media used in light and electron microscopic examination (Andrion, 1994) .
Despite the common presence of chemicals in a hospital, employees often do not perceive exposure to hazardous chemicals. In a study by Behrens (1993) , hospital employees had a 62% difference between observed and perceived exposure to chemicals. This author found most laboratory personnel have concerns about chemical odors. However, employees often will not wear respiratory protection when handling large tissue samples preserved in formalin or when using xylene to clean tissue processors, even when proper personal protective equip-
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XYLENE
Xylene is commonly used as a solvent in histology and pathology laboratories. Employees in these areas may be exposed to low levels of xylene along with other solvents and chemicals such as formaldehyde, aromatic amines, methacrylates, and glutaraldehyde. The xylene used in histology laboratories is the isomeric form of mxylene . Xylene is often identified as a concern by technologists because it has a strong aromatic odor. The odor threshold is <I ppm (.62 ppm). Often it is noticed before other low level contaminants (American Industrial Hygiene Association [AIHA], 1997). The OSHA permissible exposure limit (PEL) is 100 ppm. Worker exposures in histology labs have been documented at 19 ppm to 67 ppm, with the higher levels attributed to individuals performing weekly cleaning of automated tissue processors (Lowry, 1987) . OSHA has promulgated no specific air monitoring, safe procedures, or medicallhealth surveillance requirements for xylene. tis and corneal burns. Chronic effects include dermatitis, reversible eye damage, peripheral and central neuropathy, and liver damage. Other symptoms of chronic exposure include headache, fatigue, irritability, chronic bronchitis, and GI disturbances such as nausea and loss of appetite. It is important to note that all of the above symptoms are based on exposures >200 ppm (Genium Publishing Corporation, 1992) .
Some sources report that chronic exposure to xylene i~associated with anemia, thrombocytopenia, leukoperna, and chest pain with ECG abnormalities, dyspnea, and cyanosis (Langman, 1994) . It is not clear whether these conditions are the result of xylene exposure or exposure to a variety of solvents. Prior to the 1950s, benzene was often a contaminant of xylene and was the most likely cause of the blood dyscrasias (Andrion, 1994; Genium Publishing Corporation, 1992) . Today, xylenes have extremely small amounts of benzene contamination. Chronic exposure to high concentrations of xylene in animal studies have demonstrated mild reversible decreases in red and white cell counts as well as increases in platelet counts (Genium Publishing Corporation, 1992) . Menstrual irregularity has been reported in women with workplace exposure to xylene (Genium Publishing Corporation, 1992) . Xylene does not appear to have teratogenic effects although it does cross the human placental barrier. Based on the current literature, xylene is not considered to be carcinogenic (Andrion, 1994; Genium Publishing Corporation, 1992 , Langman, 1994 . The following procedures and medicallhealth surveillance protocols for xylene are based on the literature and effective health and safety practices.
Air Monitoring
Air monitoring for xylene should be performed annually or whenever the histology laboratory has major changes in layout or equipment. This 8 hour time weighted average (TWA) determines whether ventilation needs to be added or existing systems/procedures modified. Local exhaust ventilation should be made available if the TWA approaches one half the OSHA (50 ppm). Ventilation also should be considered if sensitive employees have exposure related complaints. In the short term, these employees can be provided with respirators containing organic vapor cartridges. However, due to the use of a variety of solvents and other chemicals in these areas, local exhaust ventilation is generally a more appropriate long term solution.
Communicating Xylene Information to Employees
Work area warnings. The hazards of xylene exposure should be communicated to affected workers in laboratory areas. For employees to be aware of the hazards, signs and warning labels must be posted in specific work areas.
Xylene container labels. Labels on xylene containers are required in the workplace. All labels must comply with the requirements of OSHA's Hazard Communication Standard, 29 CFR 1910.1200, or the Laboratory
200
Chemical Hygiene Standard, 29 CFR 1910 .1450 . Labels must remain affixed to the containers of the chemical. If container labels become ripped, tattered, or illegible, the damaged labels need to be replaced with new labels. Secondary containers also need to be labeled.
Material Safety Data Sheets (MSDSs). Material safety data sheets for xylene need to be accessible to all employees who could potentially be exposed to xylene during the course of their shift. For further information on MSDSs, the nurse can refer to the facility's written Hazard Communication program, the Chemical Hygiene Plan, OSHA's 29 CPR 1910 .1200 Hazard Communication Standard, or the Laboratory Chemical Hygiene Standard 29 CFR 1910 .1450 .
Information and training for employees working with xylene. When working with or around xylene, employees need to be informed upon initial assignment and annually thereafter about the characteristics, hazards, and protective measures. Specific information provided to employees should include: • 
Frequency of Medical/Health Surveillance
Medicallhealth surveillance examinations should be offered at least every 2 years to employees who have exposure to xylene ;a.50 ppm. Exams should also be offered to employees who have exposure related complaints on an as needed basis.
Examination Content
Xylene vapor is absorbed rapidly from the lungs, and xylene liquid and vapor are absorbed slowly through the skin. Of the xylene absorbed, about 95% is metabolized in the liver to methylhippuric acid (MHA). The kidneys then clear xylene, with 70% to 80% of metabolites excreted in the urine within 24 hours after exposure (Langman, 1994) . Many variables affect the absorption, metabolism, and clearance of xylene including exercise, alcohol intake, cigarette smoking, coexposure to other solvents, gender, and gastrointestinal, hepatic, and renal pathology. Both alcohol and exercise increase blood xylene levels. However, their effects on xylene induced central nervous system (CNS) changes were not clear or consistent in the literature (Langman, 1994; . 
Health Effects From Inhalation of Formalin

Health Effects
Exposures to formalin may occur by inhalation or skin/eye contact. Acute effects include eye, nose, and throat irritation from inhalation and dermatitis from skin contact. Table 1 The American Conference of Governmental Industrial Hygienists (1999) recommends a ceiling limit of .3 ppm. Employees exposed to formaldehyde at or exceeding the OSHA action level of .5 ppm as an 8 hour time weighted average or the short term exposure limit of 2 ppm for 15 minutes must be included in the medicallhealth surveillance program. Also included are employees who develop signs and symptoms of overexposure to formaldehyde (when exposures exceed .1 ppm) and all employees exposed in emergencies.
The OSHA Formaldehyde Standard 29 CFR 1910.1048 specifies all examinations must be performed by or under the supervision of a licensed physician. This means that any professionals licensed by their state to perform physical examinations such as a nurse practitioner or physician's assistant are acceptable, as long as they are under the supervision of a physician. The most appropriate examiner is an occupational health professional with experience performing medicallhealth surveillance examinations. However, this level of expertise is not specified in the OSHA standard. The examination must be provided without cost to the employee, without loss of pay, and at a reasonable time and place.
Follow Up
The nurse in the workplace should evaluate the work practices of an individual who has xylene related complaints or shows exposure based on biologic monitoring. Additional air monitoring may need to be performed or ventilation systems may need to be reevaluated. All follow up and exposure monitoring results need to be documented in the employee's occupational health record. As with most other occupational medicallhealth records, these records must be maintained for 30 years beyond the termination of employment.
In 1999, the American Conference of Governmental Industrial Hygienists recommended a biologic exposure index (BEl) of 1.5g methylhippuric acid/g creatinine in urine to test for xylene exposure. A simple measurement of methylhippuric acid in urine can provide information related to exposure, but the quantitative measure of exposure is weakened by the variability of urine output rate. The BEl for xylene metabolites is therefore given in relation to creatinine excretion. It is important to note that methylhippuric acid normally does not appear in the urine except with exposure to xylenes (Langman, 1994) .
Examination should start with an occupational history and physical examination by an occupational health professional. The exam should focus on the CNS, respiratory system, gastrointestinal tract, liver, kidneys, and skin. Pulmonary function testing may be needed if the employee is using a respirator or has a positive respiratory history. A urine test for methylhippuric acid follows. The MHA test needs to done at the end of shift, toward the end of the individual's work week (Langman, 1994 ). An MHA of~1.5g/g creatinine indicates exposure and needs to be followed up by the occupational or environmental health nurse. Additional testing may be added depending on the history such as an ECG, CBC, or chemistry profile (for liver and kidney function). Any employee who works with xylene and has a cardiac history or a family history of early cardiac death should receive a baseline ECG and routine follow up. Because the odor threshold is <1 ppm (AIHA, 1997), employees often attribute all symptomology to xylene exposure despite the potential for adverse reactions to other chemicals or combinations of chemicals. It is crucial to note significant symptoms only have been reported in the literature at xylene exposure levels of~200 ppm (Genium Publishing Corporation, 1992).
FORMALDEHYDE
Formaldehyde is frequently used in health care facilities to preserve tissues in histology and pathology areas. The form used for this purpose is formalin, which is 37% to 50% formaldehyde in solution. Formalin may be in a liquid or vapor form. In postmortem rooms and specimen dissection areas, average exposures in the 1980s have been reported in the range of .6 to 1.3 ppm, with occasionallevels up to 8 ppm (Andrion, 1994) .
According to the OSHA Formaldehyde Standard 29 CFR 1910.1048, the PEL as an 8 hour TWA is .75 ppm and the Short Term Exposure Limit (STEL) is 2 ppm. swelling, scaling, white discoloration, and multiple small blisters (dermatitis). Prolonged and repeated contact can cause numbness and hardening or tanning of the skin and nail dystrophy (decay). As a sensitizer, formalin may cause previously exposed employees to react to future exposure with an allergic eczematous dermatitis or hives. Skin sensitization has occurred with exposures well below .01 ppm and is usually permanent (Genium Publishing Corporation, 1992; OSHA, 1997, Appendix A) .
Injuries from eye contact with formalin range from ansient discomfort to severe, permanent corneal cloud-109 and loss of vision. The severity of the effect depends on the formaldehyde concentration in the solution and whether or not the eyes are flushed with water immediately after the incident (Genium Publishing Corporation, 1992; OSHA, 1997, Appendix A) . The eyelids of the affected person must be held open during flushing to prevent further eye damage. Flushing should begin within 10 seconds of exposure and continue for at least 15 minutes.
Formalin is considered a suspected carcinogen in humans by the International Agency for Research on Cancer, the National Toxicology Program, the National Institute of Occupational Safety and Health, and OSHA. Formalin has been associated with cancers of the lung, nasopharynx, and oropharynx, and nasal passages in humans (OSHA, 1997, Appendix A). A statistically significant increase in pharyngeal cancer has been identified in formaldehyde exposed workers. However, these results are controversial due to the small number of study participants (Genium Publishing Corporation, 1992) . Structural changes in the epithelial cells in the human nose also have been reported in the literature (Markowitz, 1994; OSHA, 1997, Appendix A) .
Prolonged or repeated exposure to formalin may result in respiratory impairment. Some individuals have developed asthma or bronchitis following formaldehyde exposure. However, most often this was as the result of an accidental spill involving a single exposure to a high concentration, not from long term, low level exposure (OSHA, 1997, Appendix A). Paustenbach (1997) cited several studies that found asthmatics were no more sensitive to formaldehyde than healthy subjects. In fact, the authors reported that bronchoconstriction occurs only at exposures of >2 ppm. Paustenbach also found chronic pulmonary diseases such as chronic obstructive pulmonary disease and emphysema are not likely to occur from long term low level occupational exposures.
Exposure at or below recommended limits does not appear to pose a reproductive hazard, but exposure to higher levels may. Some studies have reported scanty or infrequent menstruation and low birthweight children due to exposure to urea formaldehyde resin. However, the results are inconclusive. Kidney damage also has been mentioned in the literature, although it is associated only with ingestion of formaldehyde (Genium Publishing Corporation, 1992; OSHA, 1997, Appendix A).
It is important to note that perception (odor and eye irritation) of formaldehyde by employees becomes less sensitive with time due to tolerance. This may occur after only 1 or 2 hours of exposure time. Thus, employees will 202 stay in an environment with increasing formalin exposure levels and be unaware of their potential for harm (OSHA, 1997, Appendices A and D) . Therefore, formaldehyde therefore is considered to have poor warning properties and necessitates an effective air monitoring program even below the OSHA permissible exposure levels.
The following protocol outlines the procedure to be used by the occupational and environmental health nurse for administering the formaldehyde medical/health surveillance program. Unlike the procedure previously described for xylene, the protocol for formaldehyde is extensive due to detailed OSHA requirements.
Examination Frequency
The OSHA requirements for medical examinations that apply to affected employees are: • Prior to a job assignment where formaldehyde exposure is at or above a TWA of .5 ppm (action level) or 2 ppm for 15 minutes (STEL), • Annually, thereafter, and • As soon as possible upon determining that an employee is experiencing signs and symptoms indicative of possible overexposure to formaldehyde.
Examination Content
Employees included in the program need to be evaluated on the above schedule. All affected employees must complete a Medical Disease Questionnaire. The nonmandatory form provided by OSHA (1997, Appendix D) or a similar form may be used. The form used should include a medical/health history with emphasis on the respiratory system and any history of significant allergies, along with an exposure history that includes both occupational and hobby related exposures. Lifestyle exposures such as smoking also need to be recorded as smoking is known to decrease the effectiveness of the mucociliary escalator. This may subsequently increase an employee's exposure to inhaled materials such as formaldehyde vapor or other chemicals. Smoking also can be a confounding factor when determining the causality of cancer (OSHA, 1997, Appendix C) .
The physician needs to review the completed questionnaires. If the exam is an annual one, the individual's record from the previous year should be reviewed to determine if any changes occurred. OSHA does not require this process of comparison to past records, but it is critical to the effectiveness of medical/health surveillance examinations. The physician also may perform a trend analysis for the group of employees exposed to formalin in different laboratory areas to determine whether there are differences among groups.
A positive history includes evidence of eye, nose, or throat irritation, chronic airway problems or hyperreactive airway disease, allergic skin conditions or dermatitis, and upper or lower respiratory problems (OSHA, 1997) . Based on the results of the history, the exam includes the components listed in Table 2 .
The physical examination must emphasize the skin and respiratory system for evidence of irritation or sensitization, shortness of breath, or irritation of the eyes. The ACGIH (1999) currently note any necessary biologic monitoring for formaldehyde or its metabolites. Formic acid in the urine and/or formaldehyde in blood or expired air have been suggested as diagnostic tests. However, due to the high natural body production of formaldehyde (blood 2.5 ppm), and the complete rapid metabolism of the substance, these tests are considered useless (Clary, 1992; Genium Publishing Corporation, 1992) .
If an employee has a medical condition directly or indirectly aggravated by exposure to formaldehyde, the physician needs to counsel the individual about the increased risk of health impairment and possible alternative job assignments (OSHA, 1997, Appendix C). This OSHA requirement is sometimes controversial as individuals and their employers are often reluctant to alter job assignments due to "potential future risk." However, a significant risk exists for aggravating preexisting conditions such as dermatitis and respiratory disorders due to long term formalin exposure (Genium Publishing Corporation, 1992) .
Examinations for Employees Exposed In an
Emergency Employees need to have medical examinations available as soon as possible after emergency exposure to formaldehyde. The examination includes a medical and work history with emphasis on any evidence of upper or lower respiratory problems, allergic conditions, skin reaction or hypersensitivity, and eye, nose, or throat irritation. The examination otherwise includes a physical exam and other tests deemed necessary by the physician. At the time of the exam, the employer needs to provide to the examining physician a description of how the emergency occurred and the type of exposure received (OSHA, 1997) .
The following documents also need to be available to the examining physician: • A copy of 29 CFR 1910.1048 and appendices, • A description of the affected employee's duties relating to their formaldehyde exposure, • The representative exposure level for the employee's job assignment, • A description of any personal protective and respiratory equipment used or to be used, and • Information from previous medical examinations of the affected employee, not otherwise available to the examining physician but within the control of the employer.
The examining physician provides a written opinion that includes: • An opinion as to whether the employee has any detected medical conditions that would place an individual at increased risk of material health impairment from exposure to formaldehyde, • Any recommended limitations on the employee or Adapted from OSHA 29 CFR 1910 .1048 upon the use of personal protective equipment such as clothing or respirators, • A statement that the physician has informed the employee of the medical examination results, any existing condition that may be aggravated by formaldehyde, and any medical conditions resulting from formaldehyde exposure that require further explanation or treatment, and • The written opinion does not include specific nonwork related findings or diagnoses. The employer provides a copy of the physician's written opinion to the affected employee within 15 days of its receipt (OSHA, 1997) .
MedicalRemoval
If an employee reports significant irritation of the mucosa of the eyes or the upper airways, respiratory sensitization, dermal irritation, or dermal sensitization attributed to workplace formaldehyde exposure, the individual is subject to the medical removal procedure. It is important to note that medical removal does not apply in the case of dermal sensitization or dermal irritation when the product suspected of causing the dermal condition contains <.05% formaldehyde. The following section outlines this required OSHA procedure and the components that should be provided by the onsite occupational or environmental health nurse.
Procedure. The occupational or environmental health nurse discusses the employee's signs or symptoms of possible overexposure to formaldehyde with the consulting physician. If the physician believes a medical Formaldehyde and xylene are common hazards in histology and pathology laboratories. Occupational and environmental health nurses need to be familiar with the health effects that may result from exposure to these chemicals.
Although
xylene does not have medicaVhealth surveillance requirements set by OSHA, medical evaluation of employees exposed to xylene above the action level Is effective occupational and environmental health practice.
Formaldehyde exposed employees require medlcaVhealth surveillance. Occupational and environmental health nurses need to be familiar with how to implement and manage a formaldehyde surveillance program.
level of .5 ppm. The employee's earnings, seniority, and benefits are not altered during either the evaluation period or the transferred time period. If no suitable work is available, the employee's earnings, seniority, and other benefits are maintained until the problem is resolved or for up to 6 months. Some portion of the earnings may be paid through workers' compensation (OSHA, 1997) .
The occupational or environmental health nurse needs to arrange for a follow up examination within 6 months after the employee is removed. This examination determines whether the employee can be returned to the original job status or if the removal is permanent (OSHA, 1997) .
Multiple Physician Review. After the nurse selects the initial physician who conducts any medical examination or consultation to determine whether medical removal or restriction is appropriate, the employee may designate a second physician to review the initial examination results and perform a second examination. The nurse needs to promptly notify an employee of the right to seek a second opinion after each occasion an initial physician conducts a medical examination or consultation for the purpose of medical removal or restriction (OSHA, 1997) .
OSHA requires the employer to participate in and pay for multiple physicians' reviews only if the employee does the following: • Within 15 days of notiftcation of the right to seek a second medical opinion or receipt of the initial physician's written opinion (whichever is later), the employee informs the occupational or environmental health nurse (the employer) they intend to seek a second medical opinion, and • The employee schedules an appointment with a second physician.
If the findings, determinations, or recommendations of the second physician differ from those of the initial medical consultation, the nurse negotiates with the two providers to resolve the disagreement. If this is not possible, a third physician is chosen jointly by the employee and the occupational or environmental health nurse (the employer). This specialist provides the following: • A review of the prior providers' findings, determinations, or recommendations, and • Examinations, consultations, laboratory tests, and discussions with the prior physicians as deemed necessary to resolve the disagreement.
Finally, the employer is required to follow the recommendations of the examining physician whose opinion is agreed upon by both the employee and the nurse (OSHA, 1997).
CONCLUSION
Employees in histology and pathology areas are typically not exposed to xylene or formalin alone. Medicallhealth surveillance is currently required only for formalin. However, xylene and other chemicals such as dyestuffs, methacrylates, and glutaraldehyde contribute to total employee exposure. It is noted that certain benzidine dyestuffs may require medicallhealth surveillance under OSHA 1910.1003, Thirteen Carcinogens. The nurse in the workplace needs to be aware of the potential for coexposures regardless of the medicallhealth surveillance requirements. Because the affected employees may not perceive the hazard, the occupational and environmental health nurse may have a more difficult time informing hospital workers of hazards associated with their jobs. Exposure prevention and reduction strategies such as chemical substitution or local exhaust ventilation should be a priority. Presentation of exposure data and an explanation of the purpose of medicallhealth surveillance may be necessary to ensure that employees use personal protective equipment properly and comply with examination requirements.
